Vinay Prasad, Architect of Controversial Regulatory Shifts and Figure in FDA Leadership Turnover, Exits Agency for Second Time
WASHINGTON – Vinay Prasad, a prominent official at the Food and Drug Administration (FDA) whose...
Knowledge and News for the Global Fight Against Cancer.
WASHINGTON – Vinay Prasad, a prominent official at the Food and Drug Administration (FDA) whose...
Alnylam Pharmaceuticals, a leader in RNA interference (RNAi) therapeutics, has entered into a significant discovery...
The landscape of oncological care within the Department of Veterans Affairs (VA) is undergoing a...
Colorectal cancer, a formidable disease affecting the colon or rectum, is a growing public health...
The Pancreatic Cancer Action Network (PanCAN) has reaffirmed its dedication to advancing critical research and...
For decades, the scientific community has grappled with a perplexing paradox in colorectal cancer (CRC)...
A groundbreaking advancement in medical diagnostics has emerged from the Johns Hopkins Kimmel Cancer Center,...
The pharmaceutical landscape for multiple myeloma has witnessed a significant acceleration with the U.S. Food...